For patients with acute coronary syndrome (ACS) undergoing drug-eluting stent (DES) implantation, de-escalating dual ...

Over the past decade, drug-eluting stents (DES) have greatly transformed the field of interventional cardiology. Generally, three components are included in a DES system: a metal stent platform ...

Purpose: The mechanism of action and pharmacokinetics of sirolimus when used as part of a drug-eluting stent (DES) and the efficacy and cost of using DESs versus bare-metal stents are discussed.

Cardiac stent maker Sahajanand Medical Technologies Ltd, which is backed by private equity firms Morgan Stanley PE Asia ...

MUMBAI: Cardiovascular medical device manufacturer Sahajanand Medical Technologies (SMT) has appointed Bhargav Kotadia as chief executive officer and Jose Calle Gordo as chairman, effective 1 April ...

Peripheral Vascular Stent MarketThe global peripheral vascular stent market is poised for significant expansion, with an expected market value of USD 4,267.70 million in 2024. As the demand for ...

The Global Implantable Drug Delivery Devices Market was valued at USD 26.7 Bn in 2023. It is expected to reach USD 57.1 Bn by 2033, with a CAGR of 8.1% ...

The global cardiovascular devices market, valued at US$72.83 billion in 2023, is forecasted to grow at a robust CAGR of 7.3%, ...

SMT appoints Bhargav Kotadia as CEO and Jose Calle Gordo as Chairman, driving growth and innovation in cardiovascular devices ...

When lifestyle modifications and pharmacological therapies prove insufficient, interventional treatments become pivotal in managing severe cardiovascular complications among smokers. These procedures ...

Boston Scientific reorganized its operational structure and aggregated its core businesses, each of which generates revenues from the sale of Medical Devices, into two reportable segments, MedSurg (35 ...